ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) – Investment analysts at HC Wainwright issued their FY2025 EPS estimates for ASP Isotopes in a research note issued to investors on Wednesday, April 17th. HC Wainwright analyst H. Ihle expects that the company will post earnings per share of ($0.07) for the year. HC Wainwright currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for ASP Isotopes’ current full-year earnings is $0.07 per share.
ASP Isotopes Stock Performance
NASDAQ:ASPI opened at $3.04 on Thursday. The company has a market cap of $148.72 million, a price-to-earnings ratio of -6.20 and a beta of 5.03. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. ASP Isotopes has a 52 week low of $0.28 and a 52 week high of $4.97. The company has a fifty day simple moving average of $3.67 and a two-hundred day simple moving average of $2.38.
Insider Buying and Selling at ASP Isotopes
Hedge Funds Weigh In On ASP Isotopes
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ASPI. Virtu Financial LLC acquired a new position in ASP Isotopes in the 4th quarter valued at about $26,000. Millennium Management LLC acquired a new stake in ASP Isotopes in the 4th quarter worth about $49,000. HTLF Bank purchased a new stake in ASP Isotopes in the 4th quarter valued at about $141,000. Citadel Advisors LLC acquired a new position in shares of ASP Isotopes during the 4th quarter valued at about $187,000. Finally, Rathbones Group PLC purchased a new position in shares of ASP Isotopes during the 4th quarter worth about $272,000. Institutional investors and hedge funds own 16.80% of the company’s stock.
ASP Isotopes Company Profile
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Read More
- Five stocks we like better than ASP Isotopes
- What is Insider Trading? What You Can Learn from Insider Trading
- United Airlines Soars on Earnings Beat
- 3 Stocks to Consider Buying in October
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Canada Bond Market Holiday: How to Invest and Trade
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.